Global Down Syndrome

2019 Issue 3 of 4

Issue link: https://viewer.e-digitaledition.com/i/1181476

Contents of this Issue

Navigation

Page 7 of 31

A RENAISSANCE for Down Syndrome Research THE NATIONAL INSTITUTES OF HEALTH ANNOUNCES $77 MILLION ($35 MILLION NEW) IN DOWN SYNDROME RESEARCH. THANKS TO THE Global Down Syndrome Foundation's advocacy, Congressional champions, dedicated scientists, National Institutes of Health (NIH) leadership, self- advocates, and families, the NIH announced an unprecedented $77 million total for fiscal year 2019 in Down syndrome research grants, including $35 million for new research through the INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) project. The Linda Crnic Institute for Down Syndrome at the University of Colorado Anschutz Medical Campus was one of the 25 institutions selected to receive new funding. In total, Crnic Institute scientists earned 14 prestigious grants, including funding for a clinical trial aimed at curing autoimmune disorders in people with Down syndrome. In June 2018, the NIH launched the INCLUDE project in support of a Congressional directive calling for a new trans-NIH research initiative on critical health and quality of life needs for individuals with Down syndrome. This is in large part because Down syndrome had been one of the least-funded genetic conditions at the NIH for nearly two decades and because the science around the predisposition for and protection from major diseases in people with the condition holds great promise. Equally important, the televised testimony from self-advocate and Global Ambassador Frank Stephens was instrumental in securing this Congressional directive. His testimony is so compelling, it received a congressional standing ovation and the video has garnered over 150 million views online. An important support tool for INCLUDE is the NIH Down syndrome registry, DS-Connect®, that connects individuals with Down syndrome and their families to scientists and their research. We encourage everyone to sign up! Over the next several years, INCLUDE will investigate conditions that affect individuals with Down syndrome and the general population and will: • Conduct targeted, high-risk, high-reward basic science studies on chromosome 21 • Assemble a large population study of individuals with Down syndrome • Include individuals with Down syndrome in existing clinical trials From 2001 to 2006, Down syndrome funding at the NIH dropped from $29 million to $14 million during the double digit growth of the NIH budget. Until 2017, funding languished. While there is still a long way to go, Congressional directive has helped tremendously in recent years. The above char t shows a comparison between NIH funding for Down syndrome research funding as compared to autism research funding. 2019 ISSUE 3 OF 4 • DOWN SYNDROME WORLD ™ 8

Articles in this issue

Archives of this issue

view archives of Global Down Syndrome - 2019 Issue 3 of 4